"10.1371_journal.pone.0046600","plos one","2012-10-31T00:00:00Z","Adrian Schwarzer; Benita Wolf; Jan L Fisher; Thomas Schwaab; Sven Olek; Udo Baron; Craig R Tomlinson; John D Seigne; Nancy A Crosby; Jiang Gui; Thomas H Hampton; Camilo E Fadul; John A Heaney; Marc S Ernstoff","Medical Oncology Immunotherapy Group, The Geisel School of Medicine at Dartmouth, Hanover, New Hampshire, United States of America; Section of Hematology/Oncology, The Geisel School of Medicine at Dartmouth, Hanover, New Hampshire, United States of America; Epiontis GmbH, Berlin, Germany; Department of Pharmacology and Toxicology, The Geisel School of Medicine at Dartmouth, Hanover, New Hampshire, United States of America; Section of Urology, Department of Surgery, The Geisel School of Medicine at Dartmouth, Hanover, New Hampshire, United States of America; Section of Biostatistics and Epidemiology, Department of Family and Community Medicine, The Geisel School of Medicine at Dartmouth, Hanover, New Hampshire, United States of America; Immunotherapy Program, The Geisel School of Medicine at Dartmouth, Hanover, New Hampshire, United States of America; Department of Neurology, The Geisel School of Medicine at Dartmouth, Hanover, New Hampshire, United States of America","Conceived and designed the experiments: AS BW JLF CEF MSE. Performed the experiments: AS BW JLF SO UB CRT NAC JAH MSE. Analyzed the data: AS BW JLF TS SO UB CRT JDS NAC JG THH CEF JAH MSE. Contributed reagents/materials/analysis tools: SO UB CRT JG THH MSE. Wrote the paper: AS BW JLF MSE.","Sven Olek and Udo Baron work at Epiontis who did contract testing for this study under a collaborative agreement. The authors received funding from Berlex, Inc. for the clinical trial (Protocol D0238) from which patient samples reported on in this paper originated. This does not alter the authors adherence to all PLOS ONE policies on sharing data and materials.","2012","10","Adrian Schwarzer","AS",14,TRUE,5,9,14,4,TRUE,TRUE,FALSE,0,NA,FALSE
